Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply

Anton Pottegård*, David Gaist

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

OriginalsprogEngelsk
TidsskriftJAMA Internal Medicine
Vol/bind178
Udgave nummer10
Sider (fra-til)1425-1426
ISSN2168-6106
DOI
StatusUdgivet - 1. okt. 2018

Citer dette

@article{ca7fa05b301d4410a9723fa2a9d23f1d,
title = "Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply",
author = "Anton Potteg{\aa}rd and David Gaist",
year = "2018",
month = "10",
day = "1",
doi = "10.1001/jamainternmed.2018.4315",
language = "English",
volume = "178",
pages = "1425--1426",
journal = "Archives of Internal Medicine",
issn = "0003-9926",
publisher = "The JAMA Network",
number = "10",

}

Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply. / Pottegård, Anton; Gaist, David.

I: JAMA Internal Medicine, Bind 178, Nr. 10, 01.10.2018, s. 1425-1426.

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

TY - JOUR

T1 - Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply

AU - Pottegård, Anton

AU - Gaist, David

PY - 2018/10/1

Y1 - 2018/10/1

U2 - 10.1001/jamainternmed.2018.4315

DO - 10.1001/jamainternmed.2018.4315

M3 - Comment/debate

C2 - 30285138

AN - SCOPUS:85054445281

VL - 178

SP - 1425

EP - 1426

JO - Archives of Internal Medicine

JF - Archives of Internal Medicine

SN - 0003-9926

IS - 10

ER -